LarryBorishMD

Allergy & Immunology • Charlottesville, VA

Professor, Internal Medicine, University of Virginia School of Medicine

Join to view full profile

Dr. Borish is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Borish's full profile

Already have an account?

Office
Hospital Dr
Charlottesville, VA 22908
Phone+1 434-924-0000

Fax+1 434-243-7288

Education & Training

Boston University School of MedicineClass of 1979

Certifications & Licensure

VA State Medical License 1999 - 2026
CO State Medical License 1989 - 2005
American Board of Allergy and Immunology Allergy & Immunology
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Diagnostic Laboratory Immunology

Awards, Honors, & Recognition

Regional Top Doctor Castle Connolly, 2014
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
CMS Meaningful Use Stage 1 Certification EpicCare Inpatient - Core EMR, Epic Systems Corporation, 2012

Clinical Trials

Recombinant Human IL-4 Receptor Used in Treatment of Asthma Start of enrollment: 1998 May 01
Completed
Phase 2
Clinical Response to Rhinovirus Challenge Start of enrollment: 2016 Sep 01
Completed
Phase 2
Undetectable IgE as a Sentinel Biomarker for Humoral Immunodeficiency Start of enrollment: 2019 Jul 01
Completed
Phase 1
Viral Infection in Asthma (VIA) Study Start of enrollment: 2022 May 01
Recruiting
Phase 4
Join now to see all

Publications & Presentations

PubMed

Unveiling the prevalence and impact of silent rhinovirus infection in chronic rhinosinusitis with nasal polyps.
Xinyi Ma, Shu Guo, Fangying Liu, Changqing Li, Xueyun Shi
Annals of Allergy, Asthma & Immunology. 2025-01-30
Functional testing of humoral immunity in the Prevnar 20 era.
Jenna Zuzolo, Muhammad F Zulfiqar, Brian Spoelhof, Rebecca Revell, James T Patrie
Annals of Allergy, Asthma & Immunology. 2024-12-15
Modulator-refractory cystic fibrosis: Defining the scope and challenges of an emerging at-risk population.
Lindsay Somerville, Larry Borish, Imre Noth, Dana Albon
Therapeutic Advances in Respiratory Disease. 2024-11-15

Journal Articles

Insights into How Innocuous Foods or Proteins Deserving of Immune Ignorance Can Become Allergens
Larry Borish, MD, The Journal of Clinical Investigation

Authored Content

Silent Rhinovirus Infections Prevalent in Patients with CRSwNPFebruary 2025

Press Mentions

Silent Rhinovirus Infections Prevalent in Patients with CRSwNPFebruary 25th, 2025